| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MRSN (MRSN) has 13 insiders with recent SEC Form 4 filings, including 5 buys and 5 sells. MRSN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| VP | 0 | - | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2022 | Carvajal Alejandra | Chief Legal Officer | Sale+OE | 3,948 | $3.69 | $14,568.12 | -29.8% | |
| Apr 13, 2022 | Hack Andrew A. F.62 | Director | Buy | 617,284 | $4.05 | $2,500,000.20 | +8.7% | |
| Apr 12, 2022 | Hack Andrew A. F.62 | Director | Buy | 598,086 | $4.18 | $2,499,879.86 | +9.2% | |
| Feb 7, 2022 | Hack Andrew A. F.62 | Director | Buy | 1,136,363 | $4.42 | $5,022,724.46 | +21.1% | |
| Jan 18, 2022 | Lowinger Timothy B | Chief Science &Tech Off. | Sale+OE | 4,741 | $5.92 | $28,066.72 | -3.5% | |
| Jan 18, 2022 | Mandelia Ashish | VP, Controller | Sale+OE | 1,982 | $5.92 | $11,733.44 | -37.0% | |
| Dec 30, 2021 | Hack Andrew A. F.62 | Director | Buy | 815,000 | $6.15 | $5,012,250.00 | +17.8% | |
| Dec 29, 2021 | Hack Andrew A. F.62 | Director | Buy | 875,000 | $5.75 | $5,031,250.00 | +23.7% | |
| Dec 1, 2021 | Yang Arvin | Chief Medical Officer | Sale+OE | 5,527 | $6.81 | $37,638.87 | -29.9% | |
| Aug 20, 2021 | Lowinger Timothy B | Chief Science &Tech. Officer | Sale+OE | 2,216 | $11.01 | $24,398.16 | -2.9% |